The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Cell-Mediated Immune Response to Human Papillomavirus Infection
Open accessAbstract
Acquisition of human papillomavirus (HPV) results in an infection of variable duration which may or may not be associated with clinically apparent lesions. Lesions caused by skintropic HPV types generally manifest as cutaneous warts and most often resolve over a period of months to years. On the other hand, anogenital infections are more likely to remain clinically inapparent. The development of DNA amplificationbased tests has demonstrated that anogenital infections are quite common and generally self-limited. For example, we and others have shown by PCR testing of multiple samples collected at different points in time-that 70 to 90% of sexually active adolescents and young women who develop an incident cervical HPV infection will show clearance of infection within 12 to 30 months (47, 61, 94). The factors influencing the natural history of these infections are not well understood. Given that persistent anogenital infection with oncogenic HPV types is associated with increased risk of neoplasia and invasive cancers (22, 59, 70, 71, 94, 124) and that cervical carcinoma remains a leading cause of death among women in developing countries (129), understanding these factors is of considerable importance. Substantial effort has been directed recently at understanding the role of the host’s immune response in the natural history of HPV, and in particular, anti-viral, cell-mediated immunity. Empirical evidence for the importance of cell-mediated immunity in control of HPV infection comes from an extensive body of literature documenting the increased prevalence of HPV infection and associated disease among immunosuppressed populations, including those with iatrogenic immunosuppression such as renal transplant recipients and individuals with human immunodeficiency virus (HIV) infection. Sillman and coauthors (128) reported in 1984 on 20 immunosuppressed women with various causes of immunosuppression who had lower genital neoplasia, describing evidence of associated HPV infection in all 20. Penn, in 1986, reported a 100-fold increase in cancer of the vulva and anus in renal transplant recipients (111). In the 1990s, as molecular testing for HPV infection came into its own, several reports confirmed increased incidence of HPV infection (50) and associated morbidities, including warts (77) and cervical squamous intraepithelial lesions (SIL) (104), among immunosuppressed renal
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
The expanding universe of T-cell subsets: Th1, Th2 and more
Mosmann, T. R., & Sad, S. (1996) · Immunology Today · doi:10.1016/0167-5699(96)80606-2 · Cited by 3,633
Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective
Bosch, F. X., Manos, M. M., Munoz, N., Sherman, M., Jansen, A. M., Peto, J., Schiffman, M. H., Moreno, V., Kurman, R., Shan, K. V., et al. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.11.796 · Cited by 3,370
The human papilloma virus-16 E7-oncoprotein is able to bind to the retinoblastoma gene product
Dyson, N., Howley, P. M., Münger, K., & Harlow, E. (1989) · Science · doi:10.1126/science.2537532 · Cited by 3,017
Natural History of Cervicovaginal Papillomavirus Infection in Young Women
Ho, G. Y. F., Bierman, R., Beardsley, L., Chang, C. J., & Burk, R. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802123380703 · Cited by 2,329
NATURAL HISTORY OF CERVICOVAGINAL PAPILLOMAVIRUS INFECTION IN YOUNG WOMEN
Loria, G. R., Ierman, R. O. B., Eardsley, L. E. B., & Hang, H. J. C. (1998) · Cited by 1,890
Lymphocyte responses and cytokines
Paul, W. E., & Seder, R. A. (1994) · Cell · doi:10.1016/0092-8674(94)90332-8 · Cited by 1,828
A TH1→TH2 switch is a critical step in the etiology of HIV infection
Clerici, M., & Shearer, G. M. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90208-3 · Cited by 1,390
Differing Lymphokine Profiles of Functional Subsets of Human CD4 and CD8 T Cell Clones
Salgame, P., Abrams, J. S., Clayberger, C., Goldstein, H., Convit, J., Modlin, R. L., & Bloom, B. R. (1991) · Science · doi:10.1126/science.1681588 · Cited by 1,028
Koutsky, L. A., Holmes, K. K., Critchlow, C. W., Stevens, C. E., Paavonen, J., Beckmann, A. M., DeRouen, T. A., Galloway, D. A., Vernon, D., & Kiviat, N. B. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210293271804 · Cited by 943
Feltkamp, M. C. W., Smits, H. L., Vierboom, M. P. M., Minnaar, R. P., De Jongh, B. M., Drijfhout, J. W., Schegget, J. T., Melief, C. J. M., & Kast, W. M. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230929 · Cited by 825
Keratinocytes as initiators of inflammation
Barker, J. N. W. N., Griffiths, C. E. M., Nickoloff, B. J., Mitra, R. S., Dixit, V. M., & Nickoloff, B. J. (1991) · The Lancet · doi:10.1016/0140-6736(91)92168-2 · Cited by 766
HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes
Hawley‐Nelson, P., Vousden, K. H., Hubbert, N. L., Lowy, D. R., & Schiller, J. T. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08570.x · Cited by 733
Persistence of Type-Specific Human Papillomavirus Infection among Cytologically Normal Women
Hildesheim, A., Schiffman, M. H., Gravitt, P. E., Glass, A. G., Greer, C. E., Zhang, T., Scott, D. R., Rush, B. B., Lawler, P., Sherman, M. E., et al. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/169.2.235 · Cited by 682
Greenberg, P. D. (1991) · Advances in Immunology · doi:10.1016/s0065-2776(08)60778-6 · Cited by 603
Moscicki, A.-B., Shiboski, S., Broering, J., Powell, K., Clayton, L., Jay, N., Darragh, T. M., Brescia, R., Kanowitz, S., Miller, S. B., et al. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70445-7 · Cited by 564
Self-citationPicker, L., Singh, M., Zdraveski, Z., Treer, Jr., Waldrop, S., Bergstresser, P., & Maino, V. (1995) · Blood · doi:10.1182/blood.v86.4.1408.bloodjournal8641408 · Cited by 551
Human Papillomavirus Infection in Women Infected with the Human Immunodeficiency Virus
Sun, X.-W., Kuhn, L., Ellerbrock, T. V., Chiasson, M. A., Bush, T. J., & Wright, T. C. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711063371903 · Cited by 543
Palefsky, J. M., Holly, E. A., Ralston, M. L., & Jay, N. (1998) · The Journal of Infectious Diseases · doi:10.1086/514194 · Cited by 543
Palefsky, J. M., Minkoff, H., Kalish, L. A., Levine, A., Sacks, H. S., Garcia, P., Young, M., Melnick, S., Miotti, P., & Burk, R. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.3.226 · Cited by 537
Immunological Events in Regressing Genital Warts
Coleman, N., Birley, H. D. L., Renton, A. M., Hanna, N. F., Ryait, B. K., Byrne, M., Taylor-Robinson, D., & Stanley, M. A. (1994) · American Journal of Clinical Pathology · doi:10.1093/ajcp/102.6.768 · Cited by 479
Ressing, M. E., Sette, A., Brandt, R. M. P., Ruppert, J., Wentworth, P. A., Hartman, M., Oseroff, C., Grey, H. M., Melief, C. J. M., & Kast, W. M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.11.5934 · Cited by 383
Cytokine patterns in the pathogenesis of human leishmaniasis.
Pirmez, C., Yamamura, M., Uyemura, K., Paes-Oliveira, M., Conceição-Silva, F., & Modlin, R. L. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116341 · Cited by 364
Kast, W. M., Brandt, R. M. P., Sidney, J., Drijfhout, J. W., Kubo, R. T., Grey, H. M., Melief, C. J. M., & Sette, A. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.8.3904 · Cited by 345
Cancers of the anogenital region in renal transplant recipients: Analysis of 65 cases
Penn, I. (1986) · Cancer · doi:10.1002/1097-0142(19860801)58:3<611::aid-cncr2820580303>3.0.co;2-m · Cited by 329
Human Papillomavirus Infection Is Transient in Young Women: A PopulationBased Cohort Study
Evander, M., Edlund, K., Gustafsson, A., Jonsson, M., Karlsson, R., Rylander, E., & Wadell, G. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.4.1026 · Cited by 306
Cytokine production by epithelial cells 1
Stadnyk, A. W. (1994) · The FASEB Journal · doi:10.1096/fasebj.8.13.7926369 · Cited by 277
Cytokine patterns of immunologically mediated tissue damage
Yamamura, M., Wang, X. H., Ohmen, J. D., Uyemura, K., Rea, T. H., Bloom, B. R., & Modlin, R. L. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.4.1470 · Cited by 273
Barker, J. N., Sarma, V, Mitra, R. S., Dixit, V. M., & Nickoloff, B. J. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114481 · Cited by 261
Clerici, M., Ferrario, E., Trabattoni, D., Villa, M. L., Clerici, E., Merola, M., Stefanon, B., De Palo, G., Venzon, D. J., & Shearer, G. M. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.3.245 · Cited by 257
Tyring, S. K., Arany, I., Stanley, M. A., Tomai, M. A., Miller, R. L., Smith, M. H., McDermott, D. J., & Slade, H. B. (1998) · Journal of Infectious Diseases · doi:10.1086/517472 · Cited by 250
Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen.
Chen, L. P., Thomas, E. K., Hu, S. L., Hellström, I., & Hellström, K. E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.1.110 · Cited by 246
The Human Papillomavirus E7 Oncoprotein Abrogates Signaling Mediated by Interferon-α
Barnard, P., & McMillan, N. A. J. (1999) · Virology · doi:10.1006/viro.1999.9771 · Cited by 227
Crook, T., Morgenstern, J. P., Crawford, L., & Banks, L. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03405.x · Cited by 221
Infiltration of cervical cancer tissue with human papilloma virus-specific cytotoxic T-lymphocytes
Evans, E. (1997) · Immunology Letters · doi:10.1016/s0165-2478(97)88693-2 · Cited by 209
Loss of MHC class‐I expression in cervical carcinomas
Connor, M. E., & Stern, P. L. (1990) · International Journal of Cancer · doi:10.1002/ijc.2910460614 · Cited by 188
Nakagawa, M., Stites, D. P., Patel, S., Farhat, S., Scott, M., Hills, N. K., Palefsky, J. M., & Moscicki, A. (2000) · The Journal of Infectious Diseases · doi:10.1086/315706 · Cited by 175
Self-citationEffect of HIV infection on the natural history of anal human papillomavirus infection
Critchlow, C. W., Hawes, S. E., Kuypers, J. M., Goldbaum, G. M., Holmes, K. K., Surawicz, C. M., & Kiviat, N. B. (1998) · AIDS · doi:10.1097/00002030-199810000-00010 · Cited by 168
Role of cytokines in epidermal Langerhans cell migration
Wang, B., Amerio, P., & Sauder, D. N. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.66.1.33 · Cited by 167
Feltkamp, M. C. W., Vreugdenhil, G. R., Vierboom, M. P. M., Ras, E., van der Burg, S. H., Schegget, J. T., Melief, C. J. M., & Kast, W. M. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250935 · Cited by 166
Nakagawa, M., Stites, D. P., Farhat, S., Sisler, J. R., Moss, B., Kong, F., Moscicki, A., & Palefsky, J. M. (1997) · The Journal of Infectious Diseases · doi:10.1086/513992 · Cited by 165
Self-citationTsukui, T., Hildesheim, A., Schiffman, M. H., et al. (1996) · PubMed · Cited by 151
Woodworth, C. D., McMullin, E. L., Iglesias, M., et al. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2840 · Cited by 148
Subpopulations of Langerhans’ cells in cervical neoplasia
TAY, S. K., Jenkins, D. A., Maddox, P., Campion, M. J., & Singer, A. (1987) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1987.tb02244.x · Cited by 141
Th1 Cytokine Patterns in Cervical Human Papillomavirus Infection
Scott, M. E., Stites, D. P., & Moscicki, A. (1999) · Clinical and Diagnostic Laboratory Immunology · doi:10.1128/cdli.6.5.751-755.1999 · Cited by 138
Self-citationMolecular Aspects Of B-Lymphocyte Activation
DeFranco, A. L. (1987) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.03.110187.001043 · Cited by 136
MOTA, F., Rayment, N. B., CHONG, S., Singer, A., & Chain, B. (1999) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1999.00826.x · Cited by 133
Moscicki, A., Ellenberg, J. H., Vermund, S. H., Holland, C. A., Darragh, T. M., Crowley‐Nowick, P. A., Levin, L. S., & Wilson, C. M. (2000) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.154.2.127 · Cited by 132
Self-citationCytokine networks in the skin.
Schröder, J. M. (1995) · PubMed · Cited by 130
Chen, L., Mizuno, M. T., Singhal, M. C., Hu, S.-L., Galloway, D. A., Hellström, I., & Hellström, K. E. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.8.2617 · Cited by 127
Norris, D. A. (1990) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12874977 · Cited by 125
Woodworth, C. D., Notario, V., & DiPaolo, J. A. (1990) · Journal of Virology · doi:10.1128/jvi.64.10.4767-4775.1990 · Cited by 123
de Gruijl, T. D., Bontkes, H. J., Walboomers, J. M. M., Stukart, M. J., Doekhie, F. S., Remmink, A. J., Helmerhorst, T. J. M., Verheijen, R. H. M., Duggan-Keen, M. F., Stern, P. L., et al. (1998) · PubMed · Cited by 119
MINKOFF, H. L., Feldman, J. G., DeHovitz, J. A., Landesman, S. H., & Burk, R. D. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)70535-6 · Cited by 117
Al‐Saleh, W., Giannini, S. L., Jacobs, N., Moutschen, M. P., Doyen, J., Boniver, J., & Delvenne, P. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199803)184:3<283::aid-path25>3.0.co;2-k · Cited by 115
Antisense targeting of E6AP elevates p53 in HPV-infected cells but not in normal cells
Beer‐Romero, P., Glass, S., & Rolfe, M. (1997) · Oncogene · doi:10.1038/sj.onc.1200872 · Cited by 114
Woodworth, C. D., & Simpson, S. (1993) · PubMed Central · Cited by 110
T-cell lines which cooperate in generation of specific cytolytic activity
Glasebrook, A. L., & Fitch, F. W. (1979) · Nature · doi:10.1038/278171a0 · Cited by 104
Potential strategies utilised by papillomavirus to evade host immunity
Frazer, I. H., Thomas, R., Zhou, J., Leggatt, G. R., Dunn, L. A., McMillan, N. A. J., Tindle, R. W., Filgueira, L., Manders, P., Barnard, P., et al. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01288.x · Cited by 103
Youde, S. J., Dunbar, P. R., Evans, E. M., Fiander, A., Borysiewicz, L. K., Cerundolo, V., & Man, S. (2000) · PubMed · Cited by 101
MORRIS, H. H. B., Gatter, K. C., SYKES, G. S., CASEMORE, V., & Mason, D. Y. (1983) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1983.tb08936.x · Cited by 101
Soto, U., Das, B. C., Lengert, M., Finzer, P., Hausen, H. Z., & Rösl, F. (1999) · Oncogene · doi:10.1038/sj.onc.1202765 · Cited by 97
The role of dendritic cells in cutaneous immunity
Lappin, M. B., Kimber, I., & Norval, M. (1996) · Archives of Dermatological Research · doi:10.1007/bf02505819 · Cited by 96
Persistence of human papillomavirus (HPV) infections preceding cervical carcinoma
Chua, K.-L., & Hjerpe, A. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960101)77:1<121::aid-cncr20>3.0.co;2-6 · Cited by 92
Kast, W. M., Brandt, R. M. P., Drijfhout, J. W., & Melief, C. J. M. (1993) · Journal of Immunotherapy · doi:10.1097/00002371-199308000-00006 · Cited by 92
A study of anal intraepithelial neoplasia in HIV positive homosexual men
Lacey, H., Wilson, G. E., Tilston, P., Wilkins, E., BAILEY, A. S., Corbitt, G., & Green, P. M. (1999) · Sexually Transmitted Infections · doi:10.1136/sti.75.3.172 · Cited by 80
Antigen Presentation and T-Cell Activation in Epidermodysplasia Verruciformis
Cooper, K. D., Androphy, E. J., Lowy, D. R., & Katz, S. I. (1990) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12874631 · Cited by 79
Majewski, S. T., Malejczyk, J., Jablonska, S., Misiewicz, J., Rudnicka, L., Obałek, S., & Orth, G. (1990) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(90)70058-p · Cited by 77
Skin Cancer and Warts in Immunosuppressed Renal Transplant Recipients
Leigh, I. M., & Glover, M. (1995) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-78771-3_6 · Cited by 74
Schröder, J. (1995) · Journal of Investigative Dermatology · doi:10.1038/jid.1995.5 · Cited by 69
Luxton, J. C., Rowe, A. J., Cridland, J. C., Coletart, T., Wilson, P., & Shepherd, P. (1996) · Journal of General Virology · doi:10.1099/0022-1317-77-7-1585 · Cited by 68
How Dna Viruses Perturb Functional Mhc Expression To Alter Immune Recognition
McFadden, G., & Kane, K. P. (1994) · Advances in cancer research · doi:10.1016/s0065-230x(08)60400-5 · Cited by 65
Analysis of HLA‐DR expression on keratinocytes in cervical neoplasia
Coleman, N., & Stanley, M. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910560303 · Cited by 64
Connor, J. P., Ferrer, K., Kane, J. P., & Goldberg, J. M. (1999) · Gynecologic Oncology · doi:10.1006/gyno.1999.5559 · Cited by 61
Vambutas, A., Bonagura, V. R., & Steinberg, B. M. (2000) · Clinical and Diagnostic Laboratory Immunology · doi:10.1128/cdli.7.1.79-85.2000 · Cited by 61
Bontkes, H. J., de Gruijl, T. D., Walboomers, J. M. M., van den Muysenberg, A., Gunther, A., Scheper, R. J., Meijer, C. J. L. M., & Kummer, J. A. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.560 · Cited by 59
Arany, I., & Tyring, S. K. (1996) · Sexually Transmitted Diseases · doi:10.1097/00007435-199611000-00007 · Cited by 57
The Expression of Papillomaviruses in Epithelial Cells
Taichman, L. B., & LaPorta, R. F. (1987) · Springer eBooks · doi:10.1007/978-1-4757-0584-3_4 · Cited by 55
Höhn, H., Pilch, H., Günzel, S., Neukirch, C., Hilmes, C., Kaufmann, A. M., Seliger, B., & Maeurer, M. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.10.5715 · Cited by 52
Memar, O. M., Arany, I., & Tyring, S. K. (1995) · Journal of Investigative Dermatology · doi:10.1038/jid.1995.20 · Cited by 49
Malejczyk, J., Majewski, S. T., Jabłońska, S., Rogoziński, T. T., & Orth, G. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910430206 · Cited by 47
Vieira, K. B. L., Goldstein, D. J., & Villa, L. L. (1996) · PubMed · Cited by 40
Braun, L., Dürst, M., Mikumo, R., Crowley, A. C., & Robinson, M. (1992) · Molecular Carcinogenesis · doi:10.1002/mc.2940060205 · Cited by 39
Gill, D., Cason, J., Bible, J. M., Kell, B., Biswas, C., Punchard, N. A., & Best, J. M. (1998) · Journal of General Virology · doi:10.1099/0022-1317-79-8-1971 · Cited by 27
Chemokines Are Present in the Genital Tract of HIV-Seropositive and HIV-Seronegative Women
Spear, G. T., Sha, B. E., Saarloos, M. N., Benson, C. A., Rydman, R. J., Massad, L. S., Gilmore, R., & LANDAY, A. L. (1998) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199808150-00006 · Cited by 24
Konno, R., Sato, S., & Yajima, A. (1992) · International Journal of Gynecological Pathology · doi:10.1097/00004347-199204000-00004 · Cited by 18
Shier, M. K., Neely, E. B., Ward, M. G., Richards, M. E., Manders, E. C., Meyers, C., & Howett, M. K. (1999) · PubMed · Cited by 10
Shier, M. K., Neely, E. B., Ward, M. G., Meyers, C., & Howett, M. K. (1999) · PubMed · Cited by 8
Cited by
Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches
de la Cruz-López, K. G., Castro-Muñoz, L. J., Reyes-Hernández, D. O., García-Carrancá, A., & Manzo-Merino, J. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01143 · Cited by 940
“In addition, DCs present antigens to cytotoxic T lymphocytes (CTL) or CD8, these cells recognize tumor antigen through MHC-I producing the elimination of tumors (146).”
BackgroundRegression of low-grade squamous intra-epithelial lesions in young women
Moscicki, A.-B., Shiboski, S., Hills, N. K., Powell, K. J., Jay, N., Hanson, E. N., Miller, S., Canjura-Clayton, L. K., Farhat, S., Broering, J. M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17354-6 · Cited by 448
Self-citationPersistence of human papillomavirus infection: keys to malignant progression
Bodily, J., & Laimins, L. A. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2010.10.002 · Cited by 339
Human papillomavirus infection: biology, epidemiology, and prevention
SCHEURER, M. E., TORTOLERO-LUNA, G., & ADLER-STORTHZ, K. (2005) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2005.00246.x · Cited by 260
Human Papillomavirus 16 E5 Inhibits Interferon Signaling and Supports Episomal Viral Maintenance
Scott, M. L., Woodby, B. L., Ulicny, J., Raikhy, G., Orr, A. W., Songock, W. K., & Bodily, J. M. (2020) · Journal of Virology · doi:10.1128/jvi.01582-19 · Cited by 87
Self-citation
Metadata
- Authors
- Scott, M., Nakagawa, M., & Moscicki, A.-B.
- Venue
- Clinical Diagnostic Laboratory Immunology
- Publisher
- American Society for Microbiology
- Published
- 2001-03
- Volume
- 8
- Issue
- 2
- Pages
- 209-220
- ISSN
- 1071-412X (ISSN-L)
- 1098-6588
- OpenAlex
- W2137465507
- Cited by
- 273
- References
- 88
- FWCI
- 4.04
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.